OBJECTIVE: To determine whether offering home fecal immunochemical tests (FITs) to eligible patients during a high volume influenza vaccination clinic could lead to increased colorectal cancer screening (CRCS) rates in a managed care setting. STUDY DESIGN: Observational study. METHODS: During influenza vaccination clinics in 2008, trained staff provided FITs to patients who were eligible for CRCS (FLU-FIT group) (FLU indicates influenza vaccine). Screening outcomes for this cohort of patients were compared with those of a similar group of influenza clinic attendees who were not exposed to the intervention (FLUonly group). RESULTS: Among eligible participants in the FLU-only group (N = 4653), 13.7% completed FIT within 90 days of their influenza vaccine, and in the FLU-FIT group (N = 2812), 30.3% completed FIT (P <.0001). In the FLU-FIT group, 1447 (51.4%) were provided with a FIT kit, and 653 (45.1%) of these patients completed a FIT kit within 90 days. In multivariate analyses, FLU-FIT group participants were significantly more likely to complete FITs compared with FLU-only group participants (Odds Ratio = 2.76 [95% confidence interval, 2.45-3.11]). Overall, the CRCS rate for the FLU-only group increased from 51.5% to 56.3% (increase of 4.8 percentage points), compared with an increase from 49.2% to 63.2% (increase of 14.0 percentage points) in the FLU-FIT group (P lt;.0001 for change difference). CONCLUSIONS: The FLU-FIT Program is feasible to implement in a high volume influenza vaccination clinic conducted in a managed care setting and increases colorectal cancer screening activity among eligible influenza vaccination recipients who are reached with the intervention.
OBJECTIVE: To determine whether offering home fecal immunochemical tests (FITs) to eligible patients during a high volume influenza vaccination clinic could lead to increased colorectal cancer screening (CRCS) rates in a managed care setting. STUDY DESIGN: Observational study. METHODS: During influenza vaccination clinics in 2008, trained staff provided FITs to patients who were eligible for CRCS (FLU-FIT group) (FLU indicates influenza vaccine). Screening outcomes for this cohort of patients were compared with those of a similar group of influenza clinic attendees who were not exposed to the intervention (FLUonly group). RESULTS: Among eligible participants in the FLU-only group (N = 4653), 13.7% completed FIT within 90 days of their influenza vaccine, and in the FLU-FIT group (N = 2812), 30.3% completed FIT (P <.0001). In the FLU-FIT group, 1447 (51.4%) were provided with a FIT kit, and 653 (45.1%) of these patients completed a FIT kit within 90 days. In multivariate analyses, FLU-FIT group participants were significantly more likely to complete FITs compared with FLU-only group participants (Odds Ratio = 2.76 [95% confidence interval, 2.45-3.11]). Overall, the CRCS rate for the FLU-only group increased from 51.5% to 56.3% (increase of 4.8 percentage points), compared with an increase from 49.2% to 63.2% (increase of 14.0 percentage points) in the FLU-FIT group (P lt;.0001 for change difference). CONCLUSIONS: The FLU-FIT Program is feasible to implement in a high volume influenza vaccination clinic conducted in a managed care setting and increases colorectal cancer screening activity among eligible influenza vaccination recipients who are reached with the intervention.
Authors: Sheila F Castañeda; Balambal Bharti; Marielena Rojas; Silvia Mercado; Adriana M Bearse; Jasmine Camacho; Manuel Song Lopez; Fatima Muñoz; Shawne O'Connell; Lin Liu; Gregory A Talavera; Samir Gupta Journal: Am J Public Health Date: 2020-02-20 Impact factor: 9.308
Authors: Michael B Potter; Lynn M Ackerson; Vicky Gomez; Judith M E Walsh; Lawrence W Green; Theodore R Levin; Carol P Somkin Journal: Am J Public Health Date: 2013-04-18 Impact factor: 9.308
Authors: Annette E Maxwell; Leda L Danao; Reggie T Cayetano; Catherine M Crespi; Roshan Bastani Journal: Transl Behav Med Date: 2016-06 Impact factor: 3.046
Authors: Stacy N Davis; Shannon M Christy; Enmanuel A Chavarria; Rania Abdulla; Steven K Sutton; Alyssa R Schmidt; Susan T Vadaparampil; Gwendolyn P Quinn; Vani N Simmons; Chukwudi B Ufondu; Chitra Ravindra; Ida Schultz; Richard G Roetzheim; David Shibata; Cathy D Meade; Clement K Gwede Journal: Cancer Date: 2016-12-01 Impact factor: 6.860
Authors: Ana Maria Lopez; Lauren Hudson; Nathan L Vanderford; Robin Vanderpool; Jennifer Griggs; Mara Schonberg Journal: Am Soc Clin Oncol Educ Book Date: 2019-05-17
Authors: Todd Lucas; Hayley S Thompson; James Blessman; Anurag Dawadi; Caroline E Drolet; Kelly A Hirko; Louis A Penner Journal: Health Psychol Date: 2021-05 Impact factor: 4.267